Headlines

Canopy Growth Stock Impressive Rise 10% As Session Comes To An End On Friday, Outperforms Market

(VIANEWS) – Shares of Canopy Growth (NASDAQ: CGC) rose by a staggering 10.48% to $0.47 at 15:12 EST on Friday, after four sequential sessions in a row of losses. NASDAQ is rising 0.72% to $13,777.91, after two successive sessions in a row of losses. This seems, up to now, a somewhat bullish trend exchanging session today.

Canopy Growth’s last close was $0.42, 91.09% under its 52-week high of $4.77.

About Canopy Growth

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Earnings Per Share

As for profitability, Canopy Growth has a trailing twelve months EPS of $-5.2.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -151.11%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Canopy Growth’s EBITDA is -7.28.

Sales Growth

Canopy Growth’s sales growth is negative 16.8% for the current quarter and negative 14.9% for the next.

Previous days news about Canopy Growth (CGC)

  • : analyst cuts canopy growth price target to $0. According to MarketWatch on Wednesday, 5 July, "Eight Capital analyst Ty Collin on Wednesday cut his price target for Canadian cannabis company Canopy Growth Corp. to $0 from C$1.75 ($1.32) a share and reiterated a sell rating on the stock."

More news about Canopy Growth (CGC).

Leave a Reply

Your email address will not be published. Required fields are marked *